
Why Join Intellia?
Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.
Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done.
We want all of our people to go beyond what is possible. We aren’t constrained by typical end rails, and we aren’t out to just “treat” people. We’re all in this for something more. We’re driven to cure and motivated for change. Just imagine the possibilities of what we can do together.
We are a pre-commercial gene-editing company developing potential once-and-done therapies for serious diseases. Our in vivo gene-editing therapy for hereditary angioedema (HAE) is pending FDA review and poised to become the first in vivo gene-editing therapy, if approved, to reach the U.S. market. Our two global Phase 3 trials in transthyretin (TTR) amyloidosis: one in cardiomyopathy and one in polyneuropathy are well underway.
Head of Clinical Development, reporting to the CMO, will be a member of the development leadership team, accountable for partnering closely with key stakeholders in defining development strategy and oversight of clinical development activities across Intellia portfolio, including HAE and TTR. The successful candidate will be responsible for leading the cross-functional Clinical Development Team, providing strategic and medical leadership for clinical development activities of product and pipeline candidates across disease areas, in alignment with corporate strategy. This position requires a highly motivated physician scientist with hands-on expertise and player coach collaborative leadership style in advancing product candidates to deliver life-changing medicines.
EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.
Applications are accepted on a rolling basis, and will continue to be accepted until the position is filled at which point the position will be taken down.
The base salary for this position is expected to range between $394,254.00 - $481,866.00 USD per year.
The salary offered is determined based on a range of factors including, but not limited to, relevant education and training, overall related experience, specialized, rare or in-demand skill sets, internal comparators and other business needs. Upon joining Intellia, your salary will be reviewed periodically and additional factors such as time in role and performance will be considered. Intellia may change the published salary range based on company and market factors.
Additional compensation includes a performance-based annual cash bonus, a new hire equity grant, and eligibility to be considered for annual equity awards the value of which are determined annually at the Company’s discretion.
For more information about Intellia’s benefits, please click here.

Intellia Therapeutics is a leading clinical-stage biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies. The company’s mission is to transform the lives of people with severe diseases by developing and commercializing potentially curative treatments.
With deep scientific, technical and clinical development experience, Intellia aims to reset the standard for medicine by durably treating the root causes of disease. We are employing our proprietary technologies to create diverse therapeutic approaches spanning a range of diseases to realize Intellia’s full potential and address the needs of patients globally.
View our social media community guidelines at https://www.intelliatx.com/terms-and-conditions/.
Intellia Therapeutics, and the Intellia Therapeutics logo are trademarks of Intellia Therapeutics, Inc., registered in the U.S. Patent and Trademark Office and other jurisdictions. © 2026. Intellia Therapeutics, Inc.